INmune Bio Inc (INMB)
11.62
-0.22
(-1.86%)
USD |
NASDAQ |
May 01, 16:00
11.62
0.00 (0.00%)
After-Hours: 16:22
INmune Bio Price to Book Value: 5.492 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 5.596 |
| April 29, 2024 | 5.563 |
| April 26, 2024 | 5.336 |
| April 25, 2024 | 5.124 |
| April 24, 2024 | 5.020 |
| April 23, 2024 | 4.793 |
| April 22, 2024 | 5.022 |
| April 19, 2024 | 3.956 |
| April 18, 2024 | 4.159 |
| April 17, 2024 | 3.984 |
| April 16, 2024 | 4.325 |
| April 15, 2024 | 4.528 |
| April 12, 2024 | 4.911 |
| April 11, 2024 | 5.171 |
| April 10, 2024 | 5.124 |
| April 09, 2024 | 4.991 |
| April 08, 2024 | 4.897 |
| April 05, 2024 | 4.887 |
| April 04, 2024 | 4.845 |
| April 03, 2024 | 4.774 |
| April 02, 2024 | 5.176 |
| April 01, 2024 | 5.445 |
| March 28, 2024 | 5.554 |
| March 27, 2024 | 5.497 |
| March 26, 2024 | 5.592 |
| Date | Value |
|---|---|
| March 25, 2024 | 5.512 |
| March 22, 2024 | 5.742 |
| March 21, 2024 | 5.610 |
| March 20, 2024 | 5.455 |
| March 19, 2024 | 5.149 |
| March 18, 2024 | 5.187 |
| March 15, 2024 | 5.206 |
| March 14, 2024 | 5.384 |
| March 13, 2024 | 5.559 |
| March 12, 2024 | 5.535 |
| March 11, 2024 | 5.516 |
| March 08, 2024 | 5.747 |
| March 07, 2024 | 5.883 |
| March 06, 2024 | 5.954 |
| March 05, 2024 | 5.728 |
| March 04, 2024 | 6.053 |
| March 01, 2024 | 5.832 |
| February 29, 2024 | 5.460 |
| February 28, 2024 | 5.563 |
| February 27, 2024 | 5.700 |
| February 26, 2024 | 6.170 |
| February 23, 2024 | 6.081 |
| February 22, 2024 | 5.961 |
| February 21, 2024 | 5.926 |
| February 20, 2024 | 6.354 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.006
Minimum
Mar 18 2020
11.49
Maximum
Sep 07 2021
3.443
Average
2.719
Median
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 3.119 |
| Sarepta Therapeutics Inc | 14.31 |
| Dare Bioscience Inc | -- |
| Zevra Therapeutics Inc | 3.125 |
| Kodiak Sciences Inc | 0.7007 |
Price to Book Value Related Metrics
| PS Ratio | 1347.97 |
| PEG Ratio | -0.7051 |
| Price | 11.62 |
| Earnings Yield | -14.37% |
| Market Cap | 209.47M |
| PEGY Ratio | -0.7051 |